The potential for treatment with transplanted islets is greatly advantageous, removing the requirement for exogenous insulin therapy and removing many of the complications which are associated with type 1 diabetes due to the implantation of functional islets without the requirement for immunosuppressive medications associated with traditional orthotopic pancreatic transplant [22,23]. This evidence concerns the gene INS and type 1 diabetes mellitus.